Dear Friends and Colleagues,
We are delighted to invite you to take part in the 4th Biomarker Meeting: Personalized Reproductive Medicine; Biomarkers for the Assessment of Ovarian Reserve, Gametes, Embryos, Endometrium and Pregnancy.
The Congress will be held on April 12th and 13th, 2018 in Valencia, Spain. Valencia is the convergent point of different cultures, and we hope to promote new relationships, collaboration, and friendship.
The aim of the conference is to provide to the Human Reproductive field a state of the art view of the developments in personalized medicine using novel technologies that allow us to improve our clinical success using surrogate biomarkers for the majority of steps in the reproductive process and beyond in pregnancy.
The participants will be informed of the clinical application of existing and rapidly developing diagnostic technologies [deep-sequencing, genomics, transcriptomics, proteomics and metabolomics and imaging] which may help us better assess the genetic risk of the couple, ovarian reserve, gametes, embryos and endometrium with the final purpose of a healthy baby at home with increased treatment success. Also the pathological implications and biomarkers implicated in each of these processes will be analyzed. A comprehensive update of translational research in the area will be a major focal point for the conference.
Our goal is to open a forum to facilitate the exchange of knowledge and experience and to invigorate the field with young clinicians and scientist. We believe that it is time for innovation in the way we share information with each other and our patients.
We look forward to seeing you at the 4th Biomarker Meeting, and to providing you with an unforgettable scientific and social experience in the city of Valencia.
Carlos Simón, Spain Denny Sakkas, USA David Gardner, Australia Hilary Critchley, UK
Biomarker Meeting Co-Chairperson